Advertisement

Advertisement

GSK Stock Latest News

GSK’s Extended Salford Lung Study: What a Terminated Data Project Still Means for Investors

Company AnnouncementsGSK’s Extended Salford Lung Study: What a Terminated Data Project Still Means for Investors

Dodge & Cox lifts GSK stake above 5% as institutional backing grows

PremiumCompany Announcements

Dodge & Cox lifts GSK stake above 5% as institutional backing grows

3d ago

GSK Advances BALANCE Trial: New IBS Drug Candidate Moves Through Mid‑Stage Testing

PremiumCompany Announcements

GSK Advances BALANCE Trial: New IBS Drug Candidate Moves Through Mid‑Stage Testing

4d ago

GSK’s MODIFY Asthma Trial: Early Biologic Bet With Long-Term Upside Potential

PremiumCompany Announcements

GSK’s MODIFY Asthma Trial: Early Biologic Bet With Long-Term Upside Potential

4d ago

GSK Revamps Belantamab Dosing in New Multiple Myeloma Study: What Investors Should Watch

PremiumCompany Announcements

GSK Revamps Belantamab Dosing in New Multiple Myeloma Study: What Investors Should Watch

5d ago

GSK announces commencement of tender offer to acquire Nuvalent

PremiumThe FlyGSK announces commencement of tender offer to acquire Nuvalent

5d ago

Same Stock. Better Return. How STHH Quietly Outperformed STM Without Doing Anything Different

Market NewsSponsored

Same Stock. Better Return. How STHH Quietly Outperformed STM Without Doing Anything Different

6d ago

GSK Targets Relapsed B-Cell Lymphoma With New Early-Stage Trial

Company Announcements

GSK Targets Relapsed B-Cell Lymphoma With New Early-Stage Trial

11d ago

GSK’s ZEAL-1L Lung Cancer Trial Delivers Mixed Readout With Limited Upside for Niraparib

PremiumCompany Announcements

GSK’s ZEAL-1L Lung Cancer Trial Delivers Mixed Readout With Limited Upside for Niraparib

11d ago

GSK, Spero Therapeutics announce FDA approval of Utebzi

PremiumThe Fly

GSK, Spero Therapeutics announce FDA approval of Utebzi

12d ago

CMS proposes to lock in lower prices in Medicare drug price negotiation program

PremiumThe Fly

CMS proposes to lock in lower prices in Medicare drug price negotiation program

14d ago

GSK Opens New Front in Malaria Prevention With First-in-Human Antibody Trial

PremiumCompany Announcements

GSK Opens New Front in Malaria Prevention With First-in-Human Antibody Trial

17d ago

GSK announces momelotinib granted ODD from U.S. FDA, EMA

PremiumThe FlyGSK announces momelotinib granted ODD from U.S. FDA, EMA

17d ago

GSK Advances New COPD Candidate With Completed Phase 1 Ethnic-Sensitivity Study

Company Announcements

GSK Advances New COPD Candidate With Completed Phase 1 Ethnic-Sensitivity Study

18d ago

Nike downgraded, Oscar Health upgraded: Wall Street’s top analyst calls

The Fly

Nike downgraded, Oscar Health upgraded: Wall Street’s top analyst calls

19d ago

GSK’s Nuvalent Deal Strengthens Oncology Pipeline but Near‑Term EPS Dilution and Fully Valued Shares Justify Hold Rating

PremiumRatings

GSK’s Nuvalent Deal Strengthens Oncology Pipeline but Near‑Term EPS Dilution and Fully Valued Shares Justify Hold Rating

19d ago

Midday Fly By: OpenAI files for IPO, GSK to acquire Nuvalent

PremiumThe Fly

Midday Fly By: OpenAI files for IPO, GSK to acquire Nuvalent

20d ago

GSK’s Nuvalent Deal Seen as Strategically Attractive but Balanced by Execution and EPS Risks; Hold Rating and 2,350 GBp Price Target Maintained

PremiumRatings

GSK’s Nuvalent Deal Seen as Strategically Attractive but Balanced by Execution and EPS Risks; Hold Rating and 2,350 GBp Price Target Maintained

20d ago

Nuvalent downgraded to Hold from Buy at Stifel

PremiumThe Fly

Nuvalent downgraded to Hold from Buy at Stifel

20d ago

Video: Nuvalent jumps after GSK’s $10.6B takeover deal

PremiumThe FlyVideo: Nuvalent jumps after GSK’s $10.6B takeover deal

20d ago

Morning Movers: Nuvalent surges following $10.6B deal to be acquired

The Fly

Morning Movers: Nuvalent surges following $10.6B deal to be acquired

20d ago

GSK agrees to acquire Nuvalent for $124 per share

The Fly

GSK agrees to acquire Nuvalent for $124 per share

20d ago

Trending

S&P 500

―

Dow Jones

―

Nasdaq 100

―

More Trending Stocks >